Allen Natalie, Gupta Anshu
Division of Pediatric Endocrinology, Virginia Commonwealth University, Children's Hospital of Richmond, Richmond, VA 23298, USA.
Diagnostics (Basel). 2019 Mar 15;9(1):31. doi: 10.3390/diagnostics9010031.
Diabetes technology has continually evolved over the years to improve quality of life and ease of care for affected patients. Frequent blood glucose (BG) checks and multiple daily insulin injections have become standard of care in Type 1 diabetes (T1DM) management. Continuous glucose monitors (CGM) allow patients to observe and discern trends in their glycemic control. These devices improve quality of life for parents and caregivers with preset alerts for hypoglycemia. Insulin pumps have continued to improve and innovate since their emergence into the market. Hybrid closed-loop systems have harnessed the data gathered with CGM use to aid in basal insulin dosing and hypoglycemia prevention. As technology continues to progress, patients will likely have to enter less and less information into their pump system manually. In the future, we will likely see a system that requires no manual patient input and allows users to eat throughout the day without counting carbohydrates or entering in any blood sugars. As technology continues to advance, endocrinologists and diabetes providers need to stay current to better guide their patients in optimal use of emerging management tools.
多年来，糖尿病技术不断发展，以提高受影响患者的生活质量并简化护理。频繁的血糖（BG）检测和每日多次胰岛素注射已成为1型糖尿病（T1DM）管理的护理标准。连续血糖监测仪（CGM）使患者能够观察和识别其血糖控制趋势。这些设备通过预设低血糖警报，改善了父母和护理人员的生活质量。胰岛素泵自进入市场以来一直在不断改进和创新。混合闭环系统利用CGM收集的数据来辅助基础胰岛素给药和预防低血糖。随着技术的不断进步，患者可能需要手动输入到泵系统中的信息越来越少。未来，我们可能会看到一种无需患者手动输入的系统，该系统允许用户一整天无需计算碳水化合物摄入量或输入任何血糖值即可进食。随着技术的不断进步，内分泌学家和糖尿病护理人员需要紧跟潮流，以便更好地指导患者最佳使用新兴的管理工具。
